T. Vuong

2.3k total citations · 1 hit paper
10 papers, 1.7k citations indexed

About

T. Vuong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, T. Vuong has authored 10 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Otorhinolaryngology. Recurrent topics in T. Vuong's work include Head and Neck Cancer Studies (4 papers), Colorectal Cancer Surgical Treatments (2 papers) and Gastric Cancer Management and Outcomes (2 papers). T. Vuong is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Colorectal Cancer Surgical Treatments (2 papers) and Gastric Cancer Management and Outcomes (2 papers). T. Vuong collaborates with scholars based in Canada, France and United States. T. Vuong's co-authors include Michael LeBlanc, Dorit Elisabeth Schuller, K.K. Fu, A A Forastiere, George L. Adams, Wael Sakr, Muhyi Al‐Sarraf, Padmini Giri, Jay S. Cooper and John F. Ensley and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Medical Physics.

In The Last Decade

T. Vuong

10 papers receiving 1.7k citations

Hit Papers

Chemoradiotherapy versus radiotherapy in patients with ad... 1998 2026 2007 2016 1998 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Vuong Canada 6 1.4k 1.1k 776 532 137 10 1.7k
Padmini Giri United States 6 1.4k 1.0× 1.1k 1.0× 911 1.2× 590 1.1× 195 1.4× 11 1.9k
A A Forastiere United States 9 1.5k 1.1× 1.1k 1.1× 911 1.2× 605 1.1× 232 1.7× 14 2.0k
Mary Ellyn Witt United States 17 997 0.7× 710 0.7× 607 0.8× 552 1.0× 237 1.7× 24 1.5k
Nian‐Ji Cui China 15 966 0.7× 644 0.6× 624 0.8× 461 0.9× 128 0.9× 29 1.4k
Fred Rosen United States 13 846 0.6× 556 0.5× 669 0.9× 570 1.1× 241 1.8× 22 1.3k
P. Bontemps France 10 505 0.3× 415 0.4× 297 0.4× 400 0.8× 103 0.8× 34 1.1k
S. Racadot France 16 435 0.3× 375 0.4× 290 0.4× 330 0.6× 81 0.6× 72 863
J.L. Geiger United States 16 526 0.4× 469 0.4× 681 0.9× 243 0.5× 235 1.7× 92 1.3k
Tomasz Rutkowski Poland 17 419 0.3× 247 0.2× 260 0.3× 358 0.7× 233 1.7× 102 981
Emilio Minatel Italy 17 354 0.2× 230 0.2× 272 0.4× 647 1.2× 60 0.4× 58 983

Countries citing papers authored by T. Vuong

Since Specialization
Citations

This map shows the geographic impact of T. Vuong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Vuong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Vuong more than expected).

Fields of papers citing papers by T. Vuong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Vuong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Vuong. The network helps show where T. Vuong may publish in the future.

Co-authorship network of co-authors of T. Vuong

This figure shows the co-authorship network connecting the top 25 collaborators of T. Vuong. A scholar is included among the top collaborators of T. Vuong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Vuong. T. Vuong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tomic, Nada, et al.. (2024). E‐Brachy: New dosimetry package for electronic brachytherapy sources. Medical Physics. 52(1). 662–672. 1 indexed citations
2.
Al‐Sarraf, Muhyi, Michael LeBlanc, Padmini Giri, et al.. (2023). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.. Journal of Clinical Oncology. 41(24). 3965–3972. 6 indexed citations
3.
Garant, Aurélie & T. Vuong. (2017). EP-1384: Concomitant Use of Steroids and Immunotherapy in Cancer Patients: A Comprehensive Review. Radiotherapy and Oncology. 123. S741–S742. 1 indexed citations
4.
Perez, Samara, et al.. (2015). The Meaning and Experience of Patients Undergoing Rectal High-Dose-Rate Brachytherapy. Cancer Nursing. 39(1). 42–50. 4 indexed citations
5.
Vuong, T., Tamim Niazi, & Slobodan Dević. (2015). SP-0222: Role of endoluminal brachytherapy for rectal cancer: current status and challenges. Radiotherapy and Oncology. 115. S111–S112. 6 indexed citations
8.
Al‐Sarraf, Muhyi, Michael LeBlanc, Padmini Giri, et al.. (1998). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.. Journal of Clinical Oncology. 16(4). 1310–1317. 1695 indexed citations breakdown →
9.
Giri, P.G. Shankar, M. Leblanc, Muhyi Al‐Sarraf, et al.. (1996). 8 Improved survival with chemotherapy and radiation therapy versus radiation therapy alone in advanced nasopharyngeal cancer. Preliminary results of an intergroup randomized trial. Int 0099, SWOG 8892, RTOG 8817, ECOG 2388. International Journal of Radiation Oncology*Biology*Physics. 36(1). 162–162. 9 indexed citations
10.
Cosset, Jean‐Marc, M. Henry‐Amar, T. Vuong, et al.. (1991). Alternating chemotherapy and radiotherapy combination for bulky stage I and II intermediate and high grade non-Hodgkin lymphoma: an update. Radiotherapy and Oncology. 20(1). 30–37. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026